📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Omniome

1.1 - Company Overview

Omniome Logo

Omniome

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of a proprietary DNA sequencing platform delivering high-accuracy short-read sequencing using Sequencing by Binding (SBB) chemistry. Offers the Onso hardware and software system; validated exome/panel sequencing; single-cell RNA-Seq solutions; and tools for cancer research and gene editing, with lower error rates than traditional sequencing by synthesis.

Products and services

  • Onso system: Engineers a proprietary hardware-and-software platform for short-read sequencing utilizing SBB chemistry, delivering unsurpassed accuracy and validated performance with 3’ single-cell RNA-Seq libraries
  • Proprietary
  • Sequencing by binding (SBB) chemistry: Develops a short-read sequencing technology with lower error rates than traditional sequencing by synthesis, enhancing accuracy for the Onso platform and short-read applications
  • High-accuracy
  • Exome/Panels: Offers validated whole exome sequencing using third-party hybrid capture protocols for detailed genomic analysis on the Onso system, bolstering precise panel-based studies
  • Validated

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Omniome

Rancho BioSciences Logo

Rancho BioSciences

HQ: United States Website
  • Description: Provider of fee-for-service life science data curation and knowledge management, leveraging open-source tools and public domain data for Pharma, non-profit foundations, and academia. Services include data curation, data governance and models, bioinformatics analysis (including genetic variant annotation), workflows and pipelines, knowledge mining, and creation of target profiles to support research and development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rancho BioSciences company profile →
GeneCentric Therapeutics Logo

GeneCentric Therapeutics

HQ: United States Website
  • Description: Provider of molecular diagnostic tests and RNA-based informatics for oncology, including rT(I)ME Explorer for therapy-selective gene signatures, PurIST for PDAC subtyping, FGFR-PRS for identifying FGFR inhibitor candidates in urothelial cancer, AF-PRS for NSCLC chemotherapy prognosis, ICI-PRS for immune checkpoint inhibitor response prediction, and rADIO for antigen discovery and immunotherapy biomarkers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GeneCentric Therapeutics company profile →
Rewrite Therapeutics Logo

Rewrite Therapeutics

HQ: United States Website
  • Description: Provider of novel DNA writing technologies from a private biotechnology company focused on advancing the field.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rewrite Therapeutics company profile →
Seer Logo

Seer

HQ: United States Website
  • Description: Provider of proteomics tools and solutions, including the Proteograph Product Suite (integrated workflow with instruments, consumables, and software for deep, large-scale proteome analysis); Proteograph Analysis Suite for LC-MS data processing, analysis, and visualization; SP100 Automation Instrument; Proteograph Assay Kit; and Seer Technology Access Center services for proteomics research support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Seer company profile →
Sense Biodetection Logo

Sense Biodetection

HQ: United Kingdom Website
  • Description: Provider of molecular diagnostics, developing novel, user-centered handheld tests for infections and oncology, including Veros COVID-19, an instrument-free rapid COVID-19 test delivering results in about 15 minutes at the point of care without the need for specialized laboratory equipment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sense Biodetection company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Omniome

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Omniome

2.2 - Growth funds investing in similar companies to Omniome

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Omniome

4.2 - Public trading comparable groups for Omniome

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Omniome

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Omniome

What does Omniome do?

Omniome is a provider of a proprietary DNA sequencing platform delivering high-accuracy short-read sequencing using Sequencing by Binding (SBB) chemistry. Offers the Onso hardware and software system; validated exome/panel sequencing; single-cell RNA-Seq solutions; and tools for cancer research and gene editing, with lower error rates than traditional sequencing by synthesis.

Who are Omniome's competitors?

Omniome's competitors and similar companies include Rancho BioSciences, GeneCentric Therapeutics, Rewrite Therapeutics, Seer, and Sense Biodetection.

Where is Omniome headquartered?

Omniome is headquartered in United States.

How many employees does Omniome have?

Omniome has 1,000 employees 🔒.

When was Omniome founded?

Omniome was founded in 2010 🔒.

What sector and industry vertical is Omniome in?

Omniome is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Omniome

Who are the top strategic acquirers in Omniome's sector and industry

Top strategic M&A buyers and acquirers in Omniome's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Omniome?

Top strategic M&A buyers groups and sectors for Omniome include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Omniome's sector and industry vertical

Which are the top PE firms investing in Omniome's sector and industry vertical?

Top PE firms investing in Omniome's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Omniome's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Omniome's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Omniome's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Omniome include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Omniome's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Omniome?

The key public trading comparables and valuation benchmarks for Omniome include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Omniome for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Omniome with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Omniome's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Omniome with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Omniome's' sector and industry vertical?

Access recent funding rounds and capital raises in Omniome's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Omniome